Ribomic, Inc.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3974850004
JPY
94.00
-1 (-1.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Ribomic, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,017.00
-1,023.00
-1,651.00
-1,683.00
-1,185.00
-853.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
12.00
33.00
-55.00
133.00
-11.00
-81.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-996.00
-932.00
-1,708.00
-1,499.00
-1,149.00
-902.00
Cash Flow from Investing Activities
67.00
177.00
276.00
689.00
-1,699.00
553.00
Cash Flow from Financing Activities
667.00
27.00
1,333.00
354.00
4,988.00
536.00
Net Cash Inflow / Outflow
-262.00
-725.00
-76.00
-436.00
2,138.00
187.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
2.00
21.00
18.00
-1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Ribomic, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-1017.729
-676.253
-341.00
-50.50%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
12.84
23.554
-11.00
-45.49%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-996.966
-581.138
-415.00
-71.55%
Cash Flow from Investing Activities
67.178
-5.514
72.00
1318.32%
Cash Flow from Financing Activities
667.263
1065.666
-398.00
-37.39%
Net Cash Inflow / Outflow
-262.619
463.707
-725.00
-156.63%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.094
-15.307
15.00
99.39%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -6.88% vs 45.41% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-996.97
-932.76
-6.88%